For Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson, this work is deeply personal. Her story, and the stories of patients everywhere, inspire and remind us why we will never settle until the disease is behind everyone.
Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.
The company’s dedication to advancing solutions for the world’s most pressing health challenges has once again earned it a place on this annual ranking.
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.